MIRA Pharmaceuticals, Inc. (NasdaqCM: MIRA)
Health Care · Pharmaceuticals · US
$0.74
-1.19% today · -42.0% 1Y
MIRA Pharmaceuticals, Inc. (NasdaqCM: MIRA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $31.33M and employs 2 people.
Over the last twelve months the share price has lost 42.0%, trading between 0.60 and 2.45.
Tweenvest scores MIRA Pharmaceuticals, Inc. across four factors: quality 44/100, value 53/100. Its strongest factor is value.
MIRA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.33M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.86
- Dividend yield
- —
- Beta (5Y)
- 1.49
- 52-week high
- $2.45
- 52-week low
- $0.60
- Avg volume (3M)
- —
- Shares outstanding
- 42.02M
- Employees
- 2
- Next earnings
- —
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.
- ISIN
- US60458C1045
- Founded
- 2020
- Listed since
- Aug 3, 2023
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PRISM BioLab Co.,LTDTSE: 206A | $32.45M | ¥139.00 | -4.79% |
| SoftOx Solutions ASOB: SOFTX | $32.42M | Nkr0.12 | +0.67% |
| MYUNGMOON Pharm co.,LtdKOSE: A017180 | $31.98M | ₩1,286.00 | +1.02% |
| Ambalal Sarabhai Enterprises LimitedBSE: 500009 | $31.90M | Rs40.29 | +6.25% |
| BioNxt Solutions Inc.CNSX: BNXT | $31.00M | CA$0.33 | -14.47% |
| Sharp Therapeutics Corp.TSXV: SHRX | $30.85M | CA$— | — |
| Astal Laboratories LimitedBSE: 512600 | $30.84M | Rs68.14 | -2.01% |
| New Green Hemp Inc.OTCPK: NGHI | $30.79M | $— | — |
Figures last refreshed Oct 11, 2026.